Tatva Chintan Pharma Chem Limited IPO - Date, Price, GMP, Valuation, Company Strength, IPO Details

Manish Kothari
20 Likes | 691 days ago



isVerifiedExpertAuthor is a Zfunds Verified Expert
Manish Kothari

Tatva Chintan Pharma Chem Limited IPO

Incorporated in 1996, Tatva Chintan Pharma Chem limited is a specialty chemicals manufacturing company that is engaged in the manufacturing of phase transfer catalysts (PTCs), structure-directing agents (SDAs), pharmaceutical & agrochemical intermediates or other specialty chemicals, and electrolyte salts for super-capacitor batteries. It is India’s largest & only commercial manufacturer of SDAs for zeolites.

Tatva Chintan Pharma Chem has a wide application of its products in various industries like petroleum, pharmaceutical, agro-chemicals, paints, and coatings. Apart from its customer base in India, it exports its products to more than 25 countries including USA, Germany, Japan, South Africa, China, etc. 

It has two manufacturing facilities which are located in Ankleshwar and Dahej in Gujarat. Both are strategically located very close to the Hazira port.

The promoters of the company are Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani.

Strengths of the company

  • Leading manufacturer of phase transfer catalysts and structure-directing agents
  • Wide customer base with a global presence
  • Diversified specialized product portfolio
  • Modern manufacturing facilities with a focus on “green” chemistry process
  • Strong R&D capabilities

Purpose of the IPO

  • To fund the capital expenditure requirement for expansion of Dahej Manufacturing Facility.
  • To fund the capital expenditure requirement for the R&D facility in Vadodara
  • For general corporate purposes

Financial Performance of the company

 FY 2021FY 2020FY 2019
Total Revenue306.29264.62206.80
Profit After Tax52.2637.7820.54
Total Assets314.80248.93187.50

*All the values are in crores and as per RHP.

Valuation of the Company

 FY 2021FY 2020FY 2019
Basic Earnings per Share (EPS)26.0218.8110.23
Diluted Earnings per Share (EPS)26.0218.8110.23
Return on Net Worth (%)31.49%32.11%25.78%
Net Assets Value per Equity share82.6258.5939.68

*As per RHP. 

Tatva Chintan Pharma Chem Limited IPO DRHP

Tatva Chintan Pharma Chem Limited IPO RHP

IPO details

Face Value₹10 per equity share
Market Lot13 Shares
Minimum Order Quantity13 Shares
Price Band₹1,073- ₹1,083 per equity share
Issue typeBook Built Issue IPO
Issue Size₹500 Crores
Fresh Issue₹225 Crores
Offer for Sale₹275 Crores
Listing NSE, BSE

Important IPO dates

Open Date16th July 2021
Close Date20th July 2021
Basis of Allotment Date26th July 2021
Initiation of Refunds27th July 2021
The credit of shares to Demat Account28th July 2021
Listing Date29th July 2021

Allocation Quota

Qualified Institutional Buyers (QIBs)Not more than 50%
Non- Institutional Buyers (NIIs)Not less than 15%
Retail InvestorsNot less than 35%

Check your Tatva Chintan Pharma Chem Limited IPO allotment status here:

Link Intime IPO allotment Status: Click here

BSE IPO Allotment Status: Click here

NSE IPO Allotment Status: Click here.

Get Investment Advice from India's Top Experts